Description
Vogneu-0.3 contains Voglibose 0.3mg, an alpha-glucosidase inhibitor indicated for the management of Type 2 diabetes mellitus, as prescribed by a healthcare professional.
Composition:
Voglibose 0.3mg
Pack Size:
10×10 Tablets
Packing:
Blister
Therapeutic Segment:
Diabetology | Cardio-Diabetic Care
Key Benefits:
• Helps manage postprandial blood glucose levels
• Supports glycaemic control in patients with Type 2 diabetes mellitus
• Alpha-glucosidase inhibitor with established clinical use
• To be used only under medical supervision
• Convenient oral tablet formulation
Packaging:
10×10 Blister Pack
Reviews
There are no reviews yet.